Category: Research

Dr. Carolina Alday-Mondaca, and Dr. Rebecca Schiff, Provost & Vice-President Academic at the University of Lethbridge (Uleth) invite your organization to participate in a research study focused on housing challenges and support strategies for 2SLGBTIQA+ communities in Northern Canada. (See definition of north.) The study aims to understand the specific barriers, needs, and effective practices… Read more »

Substance Use News, June 2025

Substance Use News provides a monthly collection of news and resources on the social, medical and political responses to the toxic drug supply crisis and harm reduction. To get the latest toxic drug safety alerts, visit Info for People Who Use Substances page from Toward the Heart. Get weekly substance use news by subscribing to our newsletter: scroll… Read more »

Join us! Taking Action on Viral Hepatitis virtual event

We look forward to welcoming you to Taking Action on Hepatitis. July 23, 2025. 8:30 – 12 Noon Pacific time. World Hepatitis Day (WHD) is an annual day of recognition, education, and advocacy on July 28th.  Let’s break it down is the theme of this year’s WHD: “Let’s break down the barriers holding us back… Read more »

This study is looking at how the digital world affects access to health services for populations in British Columbia that are more likely to be affected by sexually transmitted and blood-borne infections (STBBI), such as HIV or hepatitis C. It also explores how community organizations are helping people navigate digital systems—and what support they need… Read more »

Via Provincial Health Service Authority: Across Canada, vulnerable populations continue to face barriers to accessing timely and equitable treatment for Sexually Transmitted and Blood-Borne Infections (STBBIs) such as Hepatitis C, Hepatitis B, HIV, and infectious syphilis. Delays in accessing prescription drug coverage are a key issue, and we want to hear about the experience of… Read more »

Substance Use News, May 2025

Substance Use News provides a monthly collection of news and resources on the social, medical and political responses to the toxic drug supply crisis and harm reduction. To get the latest toxic drug safety alerts, visit Info for People Who Use Substances page from Toward the Heart. Get weekly substance use news by subscribing to our newsletter: scroll… Read more »

  Underway now, this study explores the role of food and recipes in grieving, memory-making, and fostering connections within LGBTQ+ communities. This research aims to collect stories and recipes that memorialize loved ones, particularly those affected by the HIV/AIDS epidemic, and create a community cookbook as part of the study’s outputs. Contact Dr. Phillip Joy… Read more »

The PAN team in coordination with Central Interior Native Health Society (CINHS) HASP Program, were thrilled to host an ancillary event at the Canadian Association for HIV Research (CAHR) conference in Halifax, NS, on May 1, 2025. Jennifer Demchuk (left) and Leanne Zubowski (right) from PAN, along with Jennifer Hoy (center) from CINHS HASP, led… Read more »

Mpox Guidance Updates from the BCCDC

  Circulated by request of the BCCDC The following updates to the immunization and communicable disease guidance for Mpox will shortly be reflected here as well. Prevention and vaccination Mpox can be prevented by avoiding close contact with persons with symptoms consistent with Mpox, frequent washing of hands, covering coughs and sneezes and if at… Read more »

CBRC Summit 2025: Call for Proposals

via CBRC: We are excited to announce that we are now accepting proposals for Summit 2025, taking place November 20-22, 2025 in Montreal, QC. Each year, CBRC brings together diverse voices, impactful research, and innovative strategies to improve health outcomes for 2S/LGBTQIA+ communities. Whether your work is in community health promotion, research, or grassroots advocacy,… Read more »

  Download this poster to share. The REDOSE 2.0 study aims to better understand the concentrations and side effects of bictegravir, a commonly prescribed antiretroviral medication. This medication is part of a regimen called Biktarvy. Participation in this study is voluntary and you can withdraw at any time. All information collected will remain confidential. You… Read more »